BioCentury
ARTICLE | Company News

Antisoma, Bryan Oncor deal

August 17, 2009 7:00 AM UTC

Antisoma granted cancer company Bryan Oncor an exclusive, worldwide license to develop and commercialize P2045. The somatostatin receptor-binding peptide combined with rhenium-188 isotope has complete...